No profile data available.
BeyondSpring Inc. (BYSI) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Florham Park, United States, with about 44 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$1.01 million. Its market capitalization was $24.90 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform.
BeyondSpring reported $0 in revenue for fiscal year 2025.
$24.90 million as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Impact BioMedical Inc. (IBO), Revium Rx (RVRC), Vyome Holdings, Inc. (HIND), inTerra Resources Corp (ITRX).